Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;8(1):11-18.
doi: 10.1007/s13244-016-0531-4. Epub 2016 Nov 16.

Mammography: An Update of the EUSOBI Recommendations on Information for Women

Affiliations
Free PMC article

Mammography: An Update of the EUSOBI Recommendations on Information for Women

Francesco Sardanelli et al. Insights Imaging. .
Free PMC article

Abstract

This article summarises the information to be offered to women about mammography. After a delineation of the aim of early diagnosis of breast cancer, the difference between screening mammography and diagnostic mammography is explained. The need to bring images and reports from the previous mammogram (and from other recent breast imaging examinations) is highlighted. Mammography technique and procedure are described with particular attention to discomfort and pain experienced by a small number of women who undergo the test. Information is given on the recall during a screening programme and on the request for further work-up after a diagnostic mammography. The logic of the mammography report and of classification systems such as R1-R5 and BI-RADS is illustrated, and brief but clear information is given about the diagnostic performance of the test, with particular reference to interval cancers, i.e., those cancers that are missed at screening mammography. Moreover, the breast cancer risk due to radiation exposure from mammography is compared to the reduction in mortality obtained with the test, and the concept of overdiagnosis is presented with a reliable estimation of its extent. Information about new mammographic technologies (tomosynthesis and contrast-enhanced spectral mammography) is also given. Finally, frequently asked questions are answered.

Key points: • Direct digital mammography should be preferred to film-screen or phosphor plates. • Screening (in asymptomatic women) should be distinguished from diagnosis (in symptomatic women). • A breast symptom has to be considered even after a negative mammogram. • Digital breast tomosynthesis increases cancer detection and decreases the recall rate. • Contrast-enhanced spectral mammography can help in cancer detection and lesion characterisation.

Keywords: Breast cancer; Contrast-enhanced spectral mammography (CESM); Digital breast tomosynthesis (DBT); Mammography; Screening.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

References

    1. Sardanelli F, Helbich TH, European Society of Breast Imaging Mammography: EUSOBI recommendations for women’s information. Insights Imaging. 2012;3:7–10. doi: 10.1007/s13244-011-0127-y. - DOI - PMC - PubMed
    1. Sardanelli F, Aase H, Álvarez M et al. (2016) Position paper on screening for breast cancer by the European Society of Breast Imaging and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, and Turkey. Eur Radiol Nov 2 [Epub ahead of print] - PMC - PubMed
    1. Feig SA. Screening mammography benefit controversies: sorting the evidence. Radiol Clin N Am. 2014;52:455–480. doi: 10.1016/j.rcl.2014.02.009. - DOI - PubMed
    1. Lauby-Secretan B, Scoccianti C, Loomis D, International Agency for Research on Cancer Handbook Working Group et al. Breast Cancer Screening—viewpoint of the IARC Working Group. N Engl J Med. 2015;372:2353–2358. doi: 10.1056/NEJMsr1504363. - DOI - PubMed
    1. Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MMA. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901. doi: 10.1136/bmj.h4901. - DOI - PMC - PubMed
Feedback